Measurement of Lck expression within CLL cells from the patient reference sample showed similar reproducibility (0.49 ± 0.10), and the value recorded was significantly higher (P < 0.001) than that observed for normal B cells indicating specific binding of the anti-Lck antibody. This evidence concerns the gene LCK and B-cell chronic lymphocytic leukemia.